DEUTSCHE BANK AG\ - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 95 filers reported holding G1 THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$183,000
-28.2%
24,030
-4.1%
0.00%
Q4 2021$255,000
-18.0%
25,054
+8.1%
0.00%
Q3 2021$311,000
-40.8%
23,177
-3.0%
0.00%
Q2 2021$525,000
-14.5%
23,906
-6.2%
0.00%
Q1 2021$614,000
+2.3%
25,499
-23.6%
0.00%
Q4 2020$600,000
+144.9%
33,372
+57.9%
0.00%
Q3 2020$245,000
-83.4%
21,137
-65.3%
0.00%
-100.0%
Q2 2020$1,478,000
-69.1%
60,942
-86.0%
0.00%
-75.0%
Q1 2020$4,783,000
+1278.4%
434,001
+3196.1%
0.00%
Q4 2019$347,000
+47.0%
13,167
+26.6%
0.00%
Q3 2019$236,000
-43.9%
10,399
-24.5%
0.00%
Q2 2019$421,000
-86.1%
13,776
-92.4%
0.00%
-100.0%
Q1 2019$3,023,000
+231.8%
182,235
+282.7%
0.00%
+100.0%
Q4 2018$911,000
-85.3%
47,617
-59.8%
0.00%
-50.0%
Q3 2018$6,198,000
+65.0%
118,560
+37.1%
0.00%
+100.0%
Q2 2018$3,756,000
+187.2%
86,450
+144.6%
0.00%0.0%
Q1 2018$1,308,000
+244.2%
35,348
+84.0%
0.00%
Q4 2017$380,000
+117.1%
19,208
+171.6%
0.00%
Q3 2017$175,0007,0720.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 98,482$1,631,0000.60%
Opus Point Partners Management, LLC 20,844$346,0000.47%
HHLR ADVISORS, LTD. 949,431$15,761,0000.44%
Rhenman & Partners Asset Management AB 212,169$3,522,0000.41%
Virtus ETF Advisers LLC 8,654$144,0000.31%
BB BIOTECH AG 671,925$11,154,0000.28%
RA Capital Management 363,051$6,027,0000.26%
BDO Wealth Advisors, LLC 35,234$585,0000.17%
Birchview Capital, LP 15,000$249,0000.16%
SECOR Capital Advisors, LP 37,205$618,0000.13%
View complete list of G1 THERAPEUTICS INC shareholders